Recursion CSO David Hallett Withholds 26,657 Shares for Taxes

What Happened
David Hallett, Chief Scientific Officer of Recursion Pharmaceuticals (RXRX), had 26,657 shares withheld by the company to satisfy tax withholding obligations related to the net settlement of restricted stock units (RSUs). The shares were valued at $3.16 each, for a total of approximately $84,236. This is a tax-withholding disposition (not an open-market sale).

Key Details

• Transaction date: 2026-08-17 (reported on Form 4 filed 2026-08-18) — filing appears timely.
• Price per share: $3.16; Shares withheld/disposed: 26,657; Total value: ~$84,236.
• Transaction code: F — shares withheld to satisfy tax withholding on RSU net settlement.
• Footnote: Footnote F1 confirms the issuer withheld shares to meet its tax remittance obligations.
• Shares owned after transaction: Not specified in the provided excerpt of the filing.

Context
This was a routine tax-withholding action tied to RSU settlement (net settlement), not a market sell indicating active disposition by the insider. Such withholdings are common when equity awards vest and do not necessarily signal the insider’s view on the company’s stock.